Neuragen Science

A print-ready product information sheet is available in PDF format.

Neuragen Clinical Studies

Neuragen has been recommended by health care professionals in the USA and Canada since 1996 for the treatment of chronic pain associated with diabetic and other forms of peripheral neuropathy, shingles, fibromyalgia, post-surgical and accident induced nerve damage and other related conditions. Many patients have been successfully treated who have failed to respond to other common treatments.

Clinical Trials

LSU Clinical Trial #1

Forty subjects with all cause neuropathic pain in the feet were treated in a double blind placebo controlled trial by independent researchers at Louisiana State University. The graph below represents the average pain level for all participants before treatment (time=0) and for up to 9 hours after treatment with either Neuragen (blue drops) or placebo (green triangles). Pain relief with Neuragen was statistically significant over placebo and for up to 8 hours in duration.
 

LSU Clinical Trial #2

In a separate clinical trial also done at Louisiana State University, subjects with peripheral neuropathy received either Neuragen or no treatment over a six week intervention, as part of a larger peripheral neuropathy intervention study. Pain level was monitored on a 0-10 scale three times every week, before treatment, after treatment, and after a one-hour tai chi exercise session. As shown in the graph below, the application of Neuragen significantly reduced pain levels within five minutes and the pain relief  lasted for at least one hour. Also noted was that Neuragen treatment resulted in improved physical performance and the ability to participate in tai chi exercises.

Diabetic Neuropathy Trial

People suffering with diabetic peripheral neuropathy with pain of at least 3 months duration were invited to participate in an open label trial of Neuragen for temporary pain relief. Subjects were recruited from a California neuropathy support group, and instructed to apply Neuragen topically to the maximally painful area at least six times in one month, and complete one patient diary for each application. Efficacy was measured primarily by reduction in pain intensity over the first six hours, compared with the pain intensity before the application. Overall, 29 patients satisfactorily completed the survey. Of these, 20 patients (69%) noted some improvement in pain, with 17 patients (59%) noting a remarkable 50-100% improvement, usually within minutes.

Repeated use of Neuragen decreased overall levels of pain for some patients allowing them to use less medication overall. Also, improvement in quality of life was associated with efficacy of Neuragen including improved sleep, ability to work, social life, improved energy, and a reduction in the tendency to depressed mood.

Clinical Use of Neuragen

Neuragen has been used effectively in a clinical setting by many health care professionals for the following indications:

• Diabetic peripheral neuropathies (Hand and foot pain)
• Post-Herpetic neuralgia (post-shingles pain)
• Chemotherapy induced peripheral neuropathy
• Reflex sympathetic dystrophies (RSD)
• Fibromyalgia
• Post-surgery or accident induced neuropathy
• Causalgias
• Radiculopathies
• Phantom limb pain
• Bell’s palsy
• Trigeminal neuralgias
• Mysofascial pain
• HIV neuropathic pain
• Sciatica / spinal compression

We recommend that you consult your health care professional about combining Neuragen with your current treatment. Ask your health care professional to request the results of these clinical studies.

Safety of Neuragen

The botanical oils and its fractions used in Neuragen have been a common ingredient in foods and cosmetics for decades. In extensive clinical testing, the only detectable side effect is minor skin irritation in a slight minority of patients with sensitive skin. Please discontinue use if this occurs. There have been no reported adverse side effects when used according to directions. A flora aroma is pronounced due to the aromatic nature of the ingredients.

This information is not intended as medical advice. Its intention is solely educational. Please consult a medical or health professional for medical advice.